110 related articles for article (PubMed ID: 31938385)
21. Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
Yao JJ; He XJ; Lawrence WR; Zhang WJ; Kou J; Zhang F; Zhou GQ; Wang SY; Sun Y
Cell Physiol Biochem; 2018; 48(1):285-292. PubMed ID: 30011397
[TBL] [Abstract][Full Text] [Related]
22. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
Wen YF; Yang XZ; Zeng LS; Peng HH; Huang WJ; Cai LM; Zhou TC; Lin XD
PLoS One; 2017; 12(2):e0172345. PubMed ID: 28241022
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
25. AGR2 diagnostic value in nasopharyngeal carcinoma prognosis.
Li Y; Wang W; Liu Z; Jiang Y; Lu J; Xie H; Tang F
Clin Chim Acta; 2018 Sep; 484():323-327. PubMed ID: 29269202
[TBL] [Abstract][Full Text] [Related]
26. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification.
Xia WX; Zhang HB; Shi JL; Lu X; Wang L; Ye YF; Cao KJ; Qian CN; Guo X; Xiang YQ
Eur J Cancer; 2013 Jun; 49(9):2152-60. PubMed ID: 23571148
[TBL] [Abstract][Full Text] [Related]
27. The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.
Zuo Q; Shi M; Chen J; Liao W
Biomed Pharmacother; 2011 Jun; 65(3):168-74. PubMed ID: 21602020
[TBL] [Abstract][Full Text] [Related]
28. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
[TBL] [Abstract][Full Text] [Related]
29. [Reduced expression of Diceri is associated with poor prognosis in patients with nasopharyngeal carcinoma].
Xu S; Jiang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):126-31. PubMed ID: 25989659
[TBL] [Abstract][Full Text] [Related]
30. Significant value of
Peng H; Chen L; Tang LL; Li WF; Mao YP; Guo R; Zhang Y; Liu LZ; Tian L; Zhang X; Lin XP; Guo Y; Sun Y; Ma J
Chin J Cancer; 2017 Dec; 36(1):95. PubMed ID: 29258597
[TBL] [Abstract][Full Text] [Related]
31. Expression and Prognostic Significance of Macrophage Inflammatory Protein-3 Alpha and Cystatin A in Nasopharyngeal Carcinoma.
Tang M; Ou N; Li C; Lu A; Li J; Ma L; Zhong W; Gao J; Zheng Y; Cai Y
Biomed Res Int; 2015; 2015():617143. PubMed ID: 26634210
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
[TBL] [Abstract][Full Text] [Related]
33. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.
Tsai CL; Li HP; Lu YJ; Hsueh C; Liang Y; Chen CL; Tsao SW; Tse KP; Yu JS; Chang YS
Cancer Res; 2006 Dec; 66(24):11668-76. PubMed ID: 17178861
[TBL] [Abstract][Full Text] [Related]
34. Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.
Ren M; Wang Z; Gao G; Gu X; Wu L; Chen L
Tumour Biol; 2016 Sep; 37(9):11825-11833. PubMed ID: 27048285
[TBL] [Abstract][Full Text] [Related]
35. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
[TBL] [Abstract][Full Text] [Related]
36. Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.
He J; Cai L; Chen Y; He Y; Wang M; Tang J; Guan H; Wang J; Peng X
Radiother Oncol; 2018 Oct; 129(1):30-37. PubMed ID: 29519627
[TBL] [Abstract][Full Text] [Related]
37. [The role of retropharyngeal lymph node metastasis in staging of nasopharyngeal carcinoma].
Tang LL; Liu LZ; Ma J; Zong JF; Huang Y; Lin AH; Lu TX; Cui NJ
Ai Zheng; 2006 Feb; 25(2):129-35. PubMed ID: 16480573
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC.
Yang L; Li F; Lei F; Wang Y; Wu S; Song L; Chen Y
Tumour Biol; 2015 Sep; 36(10):7977-86. PubMed ID: 25964093
[TBL] [Abstract][Full Text] [Related]
39. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
40. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.
Luo XL; Zhong GZ; Hu LY; Chen J; Liang Y; Chen QY; Liu Q; Rao HL; Chen KL; Cai QQ
Oncotarget; 2015 Dec; 6(41):44037-48. PubMed ID: 26503474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
